.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Captopril - Generic Drug Details

« Back to Dashboard
Captopril is the generic ingredient in seven branded drugs marketed by Hikma Intl Pharms, Vintage Pharms Llc, Sandoz, Teva, Dava Pharms Inc, Wockhardt, G And W Labs Inc, Mylan, Apotex, Purepac Pharm, Par Pharm, Egis Pharms, Watson Labs, Apothecon, Prinston Inc, Stason, and Ivax Sub Teva Pharms, and is included in thirty NDAs. Additional information is available in the individual branded drug profile pages.

There are fourteen drug master file entries for captopril. Twenty-eight suppliers are listed for this compound.

Summary for Generic Name: captopril

Tradenames:7
Patents:0
Applicants:17
NDAs:30
Drug Master File Entries: see list14
Suppliers / Packaging: see list28
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices

Pharmacology for Ingredient: captopril

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
G And W Labs Inc
CAPTOPRIL
captopril
TABLET;ORAL074590-001Aug 30, 1996DISCNNo► subscribe► subscribe
Stason
CAPTOPRIL
captopril
TABLET;ORAL074677-001May 30, 1997DISCNNo► subscribe► subscribe
Watson Labs
CAPTOPRIL
captopril
TABLET;ORAL074451-001Feb 13, 1996DISCNNo► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: captopril

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Par Pharm
CAPOTEN
captopril
TABLET;ORAL018343-003Approved Prior to Jan 1, 19825,238,924► subscribe
Par Pharm
CAPOTEN
captopril
TABLET;ORAL018343-002Approved Prior to Jan 1, 19824,105,776► subscribe
Par Pharm
CAPOTEN
captopril
TABLET;ORAL018343-004Jun 13, 19954,105,776► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc